ProMedica Cardiology, Toledo, Ohio.
Mercy Hospital - North Iowa, Mason City, Iowa.
Heart Rhythm. 2018 Nov;15(11):1730-1735. doi: 10.1016/j.hrthm.2018.06.021. Epub 2018 Jun 13.
Heart rate score (HRSc) ≥70%, a novel parameter, predicts risk of mortality in patients with implantable cardioverter-defibrillators and identifies patients who have survival benefit with DDDR vs DDD pacing.
The purpose of this study was to determine if DDDR pacing lowers HRSc, and a blended sensor with minute ventilation (MV) and accelerometer (XL) improves HRSc more than accelerometer (XL) alone in patients requiring pacemakers (PMs).
HRSc, the percentage of all beats in the tallest 10-beat/min device histogram bin, was calculated. Data from the Limiting Chronotropic Incompetence for Pacemaker Recipients Study, a prospective randomized trial of PM patients, comparing XL to blended-sensor (XL + MV) rate-responsive pacing, were analyzed retrospectively for HRSc changes from baseline. The relationship of patient activity (sensor-detected from device memory) to HRSc was examined.
Of the 501 randomized patients, 215 (43%) patients had HRSc ≥70% during DDD pacing at baseline. In these patients, HRSc decreased after DDDR programming by 14.2%, while it increased by 0.4% in those with baseline HRSc <70% (n = 286) (HRSc ≥70% vs HRSc <70%; P < .01). No differences were detected between the 2 randomized sensor-based groups at baseline. Blended-sensor (MV + XL) programming reduced HRSc more than the XL sensor alone (MV + XL: 18% vs XL: 10%; P < .001). No correlation was observed between patient activity and HRSc (correlation = -0.14; P = .07).
HRSc improved (reduced) with rate-response (DDDR) programming in PM patients with high HRSc during DDD pacing. Blended sensors (MV + XL) improved HRSc more than XL alone. HRSc does not correlate with patient activity levels, suggesting that other patient factors determine this parameter. This programming approach needs to be investigated prospectively in a PM outcomes trial.
心率评分(HRSc)≥70%是一个新的参数,可预测植入式心脏复律除颤器患者的死亡率,并确定具有与 DDDR 相比具有生存获益的患者与 DDD 起搏。
本研究旨在确定 DDDR 起搏是否降低 HRSc,以及与单独使用加速度计(XL)相比,具有分钟通气量(MV)和加速度计(XL)的混合传感器是否能更好地提高需要起搏器(PM)的患者的 HRSc。
计算 HRSc,即最高 10 个 beats/min 设备直方图 bin 中的所有 beats 的百分比。从 Limiting Chronotropic Incompetence for Pacemaker Recipients 研究中回顾性分析数据,这是一项比较 PM 患者的 XL 与混合传感器(XL+MV)率反应起搏的前瞻性随机试验,分析 HRSc 从基线的变化。检查患者活动(从设备内存中检测到的传感器)与 HRSc 的关系。
在 501 名随机患者中,有 215 名(43%)患者在 DDD 起搏时基线 HRSc≥70%。在这些患者中,DDDR 编程后 HRSc 下降了 14.2%,而基线 HRSc<70%(n=286)的患者 HRSc 增加了 0.4%(HRSc≥70%与 HRSc<70%;P<.01)。在基线时,两个随机传感器组之间没有发现差异。混合传感器(MV+XL)编程比单独使用 XL 传感器(MV+XL:18%比 XL:10%;P<.001)更能降低 HRSc。没有观察到患者活动与 HRSc 之间存在相关性(相关性=-0.14;P=0.07)。
在 DDD 起搏期间 HRSc 较高的 PM 患者中,使用率反应(DDDR)编程可改善(降低)HRSc。混合传感器(MV+XL)比单独使用 XL 更能改善 HRSc。HRSc 与患者活动水平没有相关性,这表明其他患者因素决定了这个参数。这种编程方法需要在 PM 结局试验中进行前瞻性研究。